Mechanical embolectomy for treatment of large vessel acute ischemic stroke in children. by Tatum, James et al.
UCSF
UC San Francisco Previously Published Works
Title
Mechanical embolectomy for treatment of large vessel acute ischemic stroke in children.
Permalink
https://escholarship.org/uc/item/0tp2n5ts
Journal
Journal of neurointerventional surgery, 5(2)
ISSN
1759-8478
Authors
Tatum, James
Farid, Hamed
Cooke, Daniel
et al.
Publication Date
2013-03-01
DOI
10.1136/neurintsurg-2011-010100
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
ORIGINAL RESEARCH
Mechanical embolectomy for treatment of large
vessel acute ischemic stroke in children
James Tatum,1 Hamed Farid,1 Daniel Cooke,1 Heather Fullerton,2 Wade Smith,2
Randall Higashida,1,2,3 Van V Halbach,1,2,3 Christopher Dowd1,2,3
ABSTRACT
Background and purpose The three largest adult stroke
trials investigating mechanical embolectomy retrieval
devices in acute stroke (the Merci, Multi Merci and
Penumbra Pivotal Stroke Trials) excluded children. There
is a need to expand the literature on mechanical
embolectomy in large vessel pediatric arterial ischemic
stroke. This paper reports the use of two mechanical
embolectomy devices cleared by the Federal Drug
Administration (FDA) in four consecutive cases.
Methods Our pediatric stroke database from 2002 to
the present was reviewed retrospectively. Patients were
included if they were diagnosed with an acute large
vessel occlusion, were <18 years of age and underwent
recanalization with a device cleared by the FDA. Clinical
and radiographic results were abstracted from medical
record review. The Pediatric National Institutes of Health
Stroke Scale (PedNIHSS) score at presentation and at
discharge and a pediatric-modified Rankin Scale (Ped-
mRS) at approximately 90 days were scored
retrospectively based on documented examinations.
Results Four patients aged 4e17 years with
a PedNIHSS score at presentation ranging from 2 to 17
points underwent mechanical embolectomy for
reperfusion of the basilar artery (n¼3), M1 segment of
the right middle cerebral artery (n¼1) and right internal
carotid artery terminus (n¼1). Thrombolysis in cerebral
infarction (TICI) grade 3 was achieved in four vessels and
TICI grade 2A was achieved in one vessel; there was one
asymptomatic intraparenchymal hemorrhage. Intra-
arterial tissue plasminogen activator was administered in
two vessels. The PedNIHSS score at discharge ranged
from 0 to 16 points and the Ped-mRS score at
approximately 90 days ranged from 0 to 3 with 75%
achieving a Ped-mRS score of #2.
Conclusion Mechanical embolectomy using the Merci
and Penumbra systems may be a feasible therapeutic
option in the treatment of large vessel pediatric arterial
ischemic stroke.
INTRODUCTION
The incidence of pediatric stroke is estimated to be
2e13/100 000 children per year. Pediatric arterial
ischemic stroke makes up a subset of these cases
with an estimated incidence of 0.63e7.9/100 000
per year.1e3 Mortality in childhood stroke remains
low with an estimated case death rate of 2e11%,
but is offset by lifelong morbidity which is reported
to be between 68% and 74%.4 5 Sequelae of pedi-
atric stroke can manifest as deﬁcits in motor
function, language, ability to learn, behavior and
social skills.6 7 While most cases of arterial ischemic
stroke in children are classiﬁed as idiopathic, known
etiologies include focal cerebral arteriopathy, infec-
tion, cardiac disease, sickle cell disease, moya moya,
arterial dissection, vasculitis and metabolic
derangement.8 The most common presenting
symptom of stroke in young children is seizure or
hemiparesis, with seizures heralding the index
stroke 20e48% of the time.9 Moreover, hemiparesis
as a symptom of stroke may be extremely difﬁcult
to recognize in a young child and can be attributed
to other causes. Because symptoms often mimic
more common medical conditions such as migraine
headache, diagnosis and medical intervention may
be delayed.10 This often limits treatment options to
endovascular measures.
The American College of Chest Physicians, Royal
College of Physicians and American Heart Associ-
ation11 have each established guidelines to aid the
pediatric specialist in the treatment of large vessel
pediatric arterial ischemic stroke (LVPAIS). These
current guidelines are based on consensus and
expert opinion with no speciﬁc recommendations
on mechanical embolectomy.4 One potential reason
for this is the lack of data on the use of embolec-
tomy devices cleared by the Federal Drug Admin-
istration (FDA) in children and adolescents. In the
Merci, Multi Merci and Penumbra single-arm trials,
which concluded that their respective devices were
safe and effective, patients aged <18 years were
excluded. Owing to the scarcity of data, pediatric
specialists and interventionalists are forced to
extrapolate data from adult trials, postulating that
safety and efﬁcacy of mechanical embolectomy in
children parallels that in adults. Data on the use of
FDA-cleared devices off label in the setting of
LVPAIS are limited to one case report and one small
case series.12 13 The aim of this paper is to broaden
the current base of knowledge by describing our
early experience in using mechanical embolectomy
devices in LVPAIS.
METHODS
Patient selection
Our pediatric stroke database was reviewed retro-
spectively from 2003 to 2010 and four pediatric
patients who underwent mechanical revasculari-
zation for arterial ischemic stroke were identiﬁed.
Patients were included if they had a large vessel
occlusion, were less than 18 years of age and
underwent revascularization using an FDA-cleared
mechanical embolectomy device. Adjunctive use of
thrombolytics was permitted. Prior to endovascular
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therapy, all patients underwent evaluation by a pediatric
neurologist (HJF).
Endovascular procedure and post-treatment management
All patients were placed under general anesthesia before treat-
ment and underwent common femoral arterial puncture for
vascular access. A 5 or 6 Fr vascular sheath was chosen for
vascular access in children and a 7 Fr or larger vascular sheath
was used in adolescents. During procedures a normotensive
blood pressure was sought. A baseline activated clotting time
was established in three of the four patients and all patients
were anticoagulated with heparin. Thrombolytics were
administered as an adjunct in one case. The Merci retriever
(Concentric Medical, Mountain View, California, USA),
Penumbra system (Penumbra, Alameda, California, USA) or
both were employed in each case to achieve revascularization.
Following revascularization, patients were transferred to
a pediatric intensive care unit and managed by a pediatric
intensivist and a pediatric stroke neurologist (HJF). All patients
underwent follow-up imaging with MRI to assess the extent of
their infarction.
Angiographic analysis
The location of vessel occlusion, grade of collateral ﬂow14 and
perfusion following embolectomy were reported. Success of
revascularization was based on the thrombolysis in cerebral
infarction (TICI) grading system proposed by Higashida et al in
1993.14 We deﬁned successful revascularization as a TICI score of
2a or better. In addition to grading reperfusion, Higashida et al
also proposed a grading system for quantifying cerebral collateral
blood ﬂow at the time of occlusion. We reported collateral
ﬂow using this grading system, as collateral ﬂow has been
shown to correlate with stroke volume and may affect patient
outcome.15 16
Outcome assessment
A pediatric stroke neurologist (HJF) involved in the clinical care
of all four cases reviewed all available medical records and
retrospectively graded initial stroke severity and clinical
outcomes using a validated pediatric adaptation of the National
Institutes of Health Stroke Scale (PedNIHSS)17 and a previously
published but not validated pediatric adaptation of the modiﬁed
Rankin Scale (Ped-mRS).18
The Ped-mRS is graded as follows: 0, normal; 1, neurologic
deﬁcit but no impairment on daily activities; 2, neurologic deﬁcit
that interferes with daily activities, some functional use of
affected limb(s); 3, able to walk or sit up, very limited functional
use of limb, still can perform basic daily activities; 4, unable to
resume daily activities, no use of affected limb(s); 5, completely
dependent on care giver; 6, death. The PedNIHSS was graded
prior to endovascular therapy and at the time of the patient’s
discharge from hospital. The clinical evaluation closest to
90 days was used to approximate the 90-day Ped-mRS score.
RESULTS
Demographics and risk factors
Four children underwent revascularization of ﬁve large vessel
occlusions using mechanical embolectomy clot retrieval devices
for treatment of arterial ischemic stroke between 2003 and 2010
at our institution. The patients were aged 4e17 years (median
13 years). Three of the patients presented acutely without
a precipitating event. One patient had a history of posterior
circulation transient ischemic attacks and two remote posterior
circulation infarcts prior to acute presentation with a basilar
artery (BA) occlusion.
Risk factors for stroke in our series included infection, trauma,
cardiac disease and prior endovascular surgery. The etiology for
arterial ischemic stroke was suspected in each of the four
patients. A cardioembolic source was documented as the cause
in patient 1 (ﬁgure 1) and highly suspected in patient 3, and
artery-to-artery embolic events were suspected in the other two
patients. Biomarkers for hypercoagulability were measured in all
cases and found to be abnormal in two patients. The details are
summarized in table 1.
Intervention and angiographic outcome
Imaging ﬁndings, NIHSS, time to arterial puncture, time to
reperfusion, collateral grade, retrieval devices, angiographic
outcome and clinical outcome are summarized in tables 2 and 3.
Diffusion MRI/MRA (magnetic resonance angiography)
imaging was obtained in two of the four patients. In patient 4
a dense artery sign was present on non-contrast CT scanning
and an MRI was performed showing areas of restricted diffusion
in the pons. In patient 2 (ﬁgure 2) a non-contrast CT scan with
a dense artery sign was deemed sufﬁcient by the pediatric
neurologists in the context of the clinical examination to
proceed to angiography. No perfusion imaging was obtained
prior to endovascular therapy.
Time of onset of stroke to time of arterial puncture and time
of onset of stroke to reperfusion for each vascular occlusion was
recorded in hours and minutes. The median time of stroke onset
to arterial puncture was 8 h 23 min (range 4e20 h). Time of
stroke onset to reperfusion of the occluded vessel ranged from
5 h 40 min to 22 h 24 min (median 9 h 20 min). No intravenous
tissue plasminogen activator (tPA) was administered prior to
embolectomy. In patient 1, 8 mg and 6 mg of intra-arterial tPA
was given at 5 h 8 min in the BA and at 6 h 11 min in the right
middle cerebral artery (MCA) M1 segment, respectfully.
The Merci mechanical retriever system was used in isolation
in two patients and in the other two patients both systems
were employed. Different variations of the Merci retriever were
used in each case, dictated by the latest available design at the
time of the intervention and the operator ’s preference.
The 0.032 inch Penumbra system was used exclusively in
our pediatric cohort based on size recommendations by the
manufacturer.
The Merci device was successful in removing embolus in four
of the ﬁve vessels. The only failure occurred in a right internal
carotid artery (ICA) terminus occlusion in patient 1. In this
particular case only a single pass was made at the discretion of
the neuroradiologist before committing to the use of
a 0.032 inch Penumbra system that was successful in estab-
lishing TICI grade 3 perfusion. The 0.032 inch Penumbra aspi-
ration system was successful in recanalizing one of two vessels
in our series. The Penumbra system was only employed in
anterior circulation occlusions after at least one pass with the
Merci device. No failures in revascularization occurred after
establishing intent to treat and TICI grade 3 reperfusion was
achieved in 80% of vessel recanalizations.
Intravenous heparin was administered as a single bolus at the
beginning of the procedure in 75% of cases to target an activated
clotting time of 200 s. In patient 3, a heparin drip was initiated
at the outside facility and continued during the intervention at
the discretion of the operator. Only one patient received anti-
platelet medication. A single dose of 325 mg acetylsalicylic acid
was administered prior to transfer. No IIB/IIIA inhibitors were
given.
Ischemic stroke
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Clinical outcome
The PedNIHSS score on admission ranged from 2 to 17 points
(median 8.5) which improved to a score ranging from 0 to 16
(median 3) at discharge. The Ped-mRS at approximately 90 days
ranged from 0 to 3, with a score of #2 being achieved in 75% of
cases. Patient 1 had a Ped-mRS score of 3 at 30 and 90 days. In
this patient the NIHSS score failed to improve signiﬁcantly
secondary to a worsening motor examination despite an
improving mental examination.
DISCUSSION
The use of mechanical embolectomy in LVPAIS has become
more appealing as we have realized that there is an increase in
time from stroke onset to therapy in the pediatric literature
despite improved awareness in the medical community.8 In our
series we encountered a range in time from stroke onset to
arterial puncture of 4e20 h and a mean time from stroke onset
to arterial puncture of 10 h 11 min. This is signiﬁcantly different
from the mean time of stroke onset to arterial puncture of 4 h
Figure 1 A 4-year-old girl with H1N1 viral pneumonia complicated by left lower lobe streptococcal pneumonia and empyema. (A) Chest CT scan with
contrast showing filling defect (arrow) consistent with thrombus in the left atrium. (B) Diffusion-weighted imaging showing restricted diffusion in right
frontal and posterior temporal lobes and basal ganglia. (C) Diffusion-weighted imaging showing restricted diffusion in the pons. (D) Anteroposterior
(AP) Townes angiogram, right internal carotid artery (ICA) injection, showing an occlusion of the distal right ICA (small arrow) and robust temporal lobe
pial collaterals from the posterior circulation (large arrow). (E) AP Townes angiogram after embolectomy, right ICA injection, showing re-established
flow through the distal right ICA. Thrombus is seen as a filling defect in the distal right ICA (small arrow) and spasm of a proximal M2 segment (long
arrow). (F) AP Townes angiogram, left vertebral artery (VA) injection, showing occlusion of the proximal basilar artery (BA) (small arrow). (G) AP
Townes angiogram, right VA injection, showing re-establishment of flow in the BA. There is no reflux or washout of contrast from the left VA (arrow),
consistent with occlusion.
Table 1 Patient demographics, risk factors, abnormal laboratory values and suspected etiology
Patient
Presentation/neurologic
examination Risk factor(s)
Abnormal hematologic
laboratory values Suspected etiology
1 Agitated/bilateral HP (Lt>Rt), dilated
Rt pupil (6 mm), Rt gaze, clonus BLE
H1N1/streptococcal pneumonia,
streptococcal bacteremia
e C: Lt atrial thrombus*
2 Awake/Lt HP, Lt FD H/O right ECA fistula embolization Lipoprotein A 97 (<75),
protein C 71% (76e146%)
A: Stump embolus from
dilated Rt ECA
3 Awake, vertigo, diplopia/INO, 6th NP 2.7 mm PFO e C: Cardiac embolus
4 Rt arm and tongue numbness, diplopia/INO H/O C-spine trauma with undiagnosed dens
fracture resulting in repetitive trauma to VA,
bilateral VA FMD with H/O Rt VA dissection,
recurrent posterior fossa strokes
+MTHFRy A: Arterial thrombus
*Definite etiology.
yHomozygous.
A, arterial; BLE, bilateral lower extremity; C, cardiac; ECA, external carotid artery; FD, facial droop, FMD, fibromuscular dysplasia; H/O, history of; HP, hemiparesis; INO, internuclear
ophthalmoplegia; Lt, left; MTHFR, methylenetetrahydrofolate reductase; NP, nerve palsy; PFO, patent foramen ovale; Rt, right; VA, vertebral artery.
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18 min reported in the Pivotal Penumbra, Merci and Multi Merci
trials and probably reﬂects the many mimics and non-speciﬁc
presentation of LVPAIS.19 This increase in time to therapy was
conﬁrmed in a recent study by Rafay et al which found that 68%
of children with stroke present to hospital within 3 h of
symptom onset, qualifying them for intravenous tPA; however,
only 20% of these same patients were diagnosed with stroke
within 6 h, limiting therapeutic options.10 Moreover, like other
tertiary centers, many of the children with stroke are referred to
our facility because of inexperience in treating pediatric stroke in
the community, and the transfer time adds to the overall time to
endovascular therapy. These clinical challenges can make it quite
difﬁcult to render deﬁnitive care in a relevant period of time
when intravenous or intra-arterial thrombolysis may be
a feasible therapeutic option.
The two FDA-cleared devices for retrieval of emboli and
thrombus currently on the market are the Merci and Penumbra
systems, and these two systems were used exclusively in our
study. The Merci retrieval device is a corkscrew-shaped nitinol
wire which engages the clot for retrieval into a guide catheter.
This is facilitated with proximal occlusion of ﬂow by inﬂating
a balloon on the guide catheter transiently during clot retrieval.
In our series, the use of the balloon guide catheter was limited to
larger children because of the size of the catheter (available in
7e9 Fr only).
The Penumbra system uses a speciﬁcally designed system to
macerate and then aspirate the embolus. As the catheter is
moved distally through the embolus or thrombus it is cleared
periodically with a separator wire under a constant vacuum. The
decision as to which device to use in our study was based on
device availability at the time of the procedure, clinical expe-
rience and operator preference. There was a bias towards using
the Merci device ﬁrst in our series, reﬂecting its availability in
earlier cases before the advent of the Penumbra system and the
operator ’s comfort level with the device.
The size of device used in our series was tailored to the size of
the target vascular anatomy. The Merci device was sized to the
target vessel diameter. The choice of ﬁrm or soft was based on
operator experience and preference. The size of the Penumbra
system was based on the manufacturer ’s recommendations.
Penumbra recommends using a 0.032 inch system in vessels of
2.0e3.0 mm, which was why we chose to use this size in
patients 1 and 2.
We achieved success in recanalization with both devices, but
a comparison between the devices is difﬁcult for several reasons.
First, this is a limited study based on a small number of patients
and device successes and failures may be under-represented in
such a small cohort. Second, there was crossover between the
devices, making it difﬁcult to make a fair comparison between
systems. One device could have facilitated the re-establishment
of blood ﬂow even though the device was not successful in
primarily recanalizing the vessel. Lastly, the established selection
bias by the operator in making the decision to abandon one
device in favor of the other, was not controlled for in this study,
affecting the success of each device.
In our series we achieved a 100% recanalization rate and
encountered a 25% rate of intracranial hemorrhage, which
is comparable with the rate of 27e35.5% in published
adult mechanical embolectomy trials.20 21 The asymptomatic
hemorrhage in our series occurred in the right basal ganglia in
patient 2, and was suspected with the development of a small
arterial to venous shunt noted on digital subtraction angiog-
raphy (DSA) following reperfusion. In the same patient there
was contrast staining of the angular cortex on post-procedural
non-contrast CT scanning without deﬁnitive subarachnoid
hemorrhage (SAH) being noted. However, an adjacent ﬂair
signal abnormality in the subarachnoid space was seen on the
MRI scan, suggesting a focal SAH had occurred. The etiology of
this SAH, if real, is unclear. In this case, the Merci devices
were deployed in the proximal M2 segment and we postulate
that traction with this device could have led to a small avul-
sion hemorrhage of more distal insular perforators. The loca-
tion of Merci deployment and lack of focal vessel abnormality
on DSA would argue against a dissection as the etiology of the
Table 2 Imaging findings, retrieval device and angiographic outcome
Patient
Pre-procedure
imaging modality
Pre-procedure imaging
findings Site of occlusion
Embolectomy device
(number of passes) TICI score Post-procedure MRI findings
1 MRI/MRA RD in Rt>Lt pons, Rt
MCA territory, Rt BG
Mid-BA,
Rt ICA terminus
Merci 2.5 mm firm, BA (2);
Merci 2.5 mm firm, Rt ICA (1);
0.032 inch Penumbra, Rt ICA
3 (BA); 2A
(Rt ICA)
RD in Rt>Lt pons, Rt
MCA territory, Rt BG
2 NCCT Hyperdense Rt MCA Rt M1 segment L4 Merci (1); 0.032 inch
Penumbra; Merci 2.5 mm
soft (1)
3 RD in Rt BG
3 NCCT
CTA
MRI
Multiple foci of RD Rt pons,
focus of RD Lt PMJ
Mid-BA Merci X6 (1) 3 Multiple foci of RD, Rt pons,
focus of RD Lt PMJ
4 NCCT
MRI
Multiple foci of RD bilateral
pons, focus of RD Lt cerebellar
hemisphere
Mid-BA Merci K mini (1) 3 Multiple foci of RD bilateral
pons, focus of RD Lt cerebellar
hemisphere
BA, basilar artery; BG, basal ganglia; CTA, CT angiogram; ICA, internal carotid artery; Lt, left; MCA, middle carotid artery; NCCT, non-contrast CT; PMJ, pontomedullary junction; RD, reduced
diffusion; Rt, right.
Table 3 NIHSS, time to arterial puncture, time to reperfusion, collateral grade and outcome
Patient PedNIHSS (P) Time to arterial puncture Time to reperfusion Collateral grade PedNIHSS (D) Ped-mRS (90 days)
1 17 4 h 5 h 40 min (BA), 6 h
36 min (right ICA)
1 (BA),
2 (right ICA)
16 3
2 12 7 h 30 min 9 h 20 min 3 3 1
3 2 9 h 15 min 10 h 2 0 0
4 5 20 h 22 h 24 min 1 3 0
BA, basilar artery; D, discharge; ICA, internal carotid artery; Ped-mRS, pediatric modified Rankin Scale; PedNHISS, pediatric National Institutes of Health Stroke Scale; P, presentation.
Ischemic stroke
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SAH. Short-term follow-up demonstrated complete resolution
of the suspected SAH and no increase in size of the intra-
parenchymal hemorrhage. Reperfusion occurred 9 h 20 min
after the onset of symptoms, and the absence of thrombolytics
in this case may have lessened the chance of a symptomatic
hemorrhage.
Although we did not experience a symptomatic hemorrhage
in our study, this is probably the result of undersampling given
our small cohort. If we assume a risk of symptomatic hemor-
rhage of 10e11% as demonstrated in adult embolectomy
trials,20 22 we would require a cohort of at least 11 patients to
expect to see one symptomatic hemorrhage.
Others have described the use of mechanical embolectomy
devices in children. Tsivgoulis et al13 described a case of a right
ICA terminus occlusion in a 6-year-old boy that was recanalized
with the use of a Merci device. No hemorrhage was reported on
short-term follow-up (table 4). Grunwald et al12 described the
use of the Penumbra system in two pediatric patients without
hemorrhage. One case involved a distal left ICA occlusion in a 7-
year-old boy with clot propagation into the left M1 segment.
The patient presented with right hemiplegia and recanalization
was achieved within 10 min of arterial puncture. The second
case involved a 16-year-old comatose girl with a BA occlusion.
She underwent recanalization within 2 min after microcatheter
Figure 2 A 10-year-old boy presented with an acute left hemiparesis and facial droop. (A) Non-contrast CT (NCCT) scan showing coils (arrow) in the
location of the right hypoglossal canal. (B) NCCT scan showing a hyperdense sign in the right middle cerebral artery (MCA) (arrow). (C) Digital subtraction
angiogram (DSA), right common carotid artery (CCA) injection, right anterior oblique (RAO) projection, showing enlarged patulous proximal external
carotid artery (ECA) and internal maxillary artery ending in a blind pouch (arrow). The nest of coils seen in (A) is subtracted from the image (asterisk). (D)
DSA, right internal carotid artery (ICA) injection, anteroposterior (AP) projection, showing an occlusion of the distal right M1 segment (large arrow). Pial
collaterals are seen from the right anterior cerebral artery (small arrow) retrogradely filling the right MCA territory. (E) DSA, right ICA injection, AP
projection, showing re-establishment of blood flow in the right MCA. (F) NCCT scan within 24 h following reperfusion showing contrast staining of the
parenchyma (arrow) in the right temporal lobe. (G) T2-weighted flair image showing increased signal in the head of the caudate, globus pallidus and
putamen. (H) T2-weighted GRE image showing a linear low signal (arrow) in the right putamen reflecting a small intraparenchymal hemorrhage. (I)
Outside Hospital (OSH) DSA from 2007, obtained following stroke intervention, injection right ECA, RAO projection, showing an ascending pharyngeal
artery (APA) to internal jugular vein fistula (asterisk). The APA is dilated and patulous (black arrows). Blood is shunted into the intraparietal sulcus (small
white arrow), cavernous sinus (arrowhead) and superior ophthalmic vein (large white arrow). (J) DSA from 2007, right CCA injection, AP projection,
following treatment of the fistula showing a large patulous right ECA and APA (black arrow) over twice the size of the ICA. This appearance is similar to
the current DSA, demonstrating lack of autoregulation over time. In comparison, the internal maxillary artery is small (white arrow).
Table 4 Comparison of published pediatric mechanical embolectomy cases
Current study Grunwald et al12 Tsivgoulis et al13
Age (n) 4e17 (4) 7e16 (2) 6 (1)
Mean NHISS at baseline 9 31 17
Mean change from baseline
in NIHSS at discharge
3.5 19.5 11
Location of occlusion Anterior circulation (n¼2) Anterior circulation (n¼1) Anterior circulation (n¼1)
Posterior circulation (n¼3) Posterior circulation (n¼1)
Device Merci/Penumbra Penumbra Merci
Asymptomatic hemorrhage 1 0 0
Symptomatic hemorrhage 0 0 0
Mean mRS at 90 days 1* Not reported 1
*Pediatric mRS.
mRS, modified Rankin Scale; NHISS, National Institutes of Health Stroke Scale.
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placement. In both cases, they were successful in achieving
thrombolysis in myocardial infarction 3 reperfusion scores with
the use of a 0.41 inch Penumbra system. In the BA occlusion, the
authors administered intra-arterial thrombolytics at 8 h as
adjunctive therapy to mechanical embolectomy. They also chose
to use a larger Penumbra system which may have partially
inﬂuenced the differences in recanalization times between their
study and ours.
In the cases by Tsivgoulis et al, Grunwald et al and in our
study, thrombolytics were used in speciﬁc cases as adjunctive
therapy. Typically, the dosage and timing of thrombolytics in
these cases is based on extrapolated data from adult trials23
without pediatric-speciﬁc guidelines.4 24 Dosing of thrombo-
lytics is complicated by differences in concentrations of
endogenous tPA and plasminogen activator inhibitor-1 in chil-
dren compared with adults, making it difﬁcult to extrapolate
safe and effective dosing of ﬁbrinolytics in children from adult
data.25 Although still undeﬁned, the safety of thrombolytics in
children has been supported in a recent review by Arnold et al.
They evaluated all reported pediatric cases of intravenous and
intra-arterial thrombolysis in large vessel occlusions.26 Dosing
was heterogeneous, but no symptomatic hemorrhage was
detected and only two asymptomatic hemorrhages were
identiﬁed when thrombolytics were administered within 8 h.
The data from this review are in agreement with our own
experience and those reported by Grunwald et al and Tsivgoulis
et al 12 13 However, while these data are promising, the lack of
current dosing guidelines for intravenous or intra-arterial tPA in
children highlights the theoretical advantage of mechanical
embolectomy.
The etiology of stroke encountered in our population did not
differ from those reported elsewhere4 9 25e28 and included vessel
injury, prior surgery, patent foramen ovale and infection leading
to cardiac thrombus formation. The decision to treat in each
case was collectively made by the neurointerventionalist and the
pediatric neurology service on an individual basis and was based
on stroke severity and location of the vascular occlusion. We did
not base our decision to treat on perfusion imaging because, to
our knowledge, no prospective studies have validated the prog-
nostic ability of imaging to predict outcome and complete stroke
volume in pediatric patients and thereby exclude them from
interventional therapy. We limited our window of therapy to 6 h
for intra-arterial thrombolytics and 8 h for embolectomy in
anterior circulation occlusions based on current adult data.
However, we did not limit our mechanical embolectomy
therapy to an established time window for BA occlusions.
Both patients with BA occlusions presented with low NIHSS
scores more than 8 h after symptom onset. The potential
lethality, unclear natural course and potentially poor outcome of
these lesions29 played a primary role in our decision to treat. We
were particularly concerned about the potential for propagation
of thrombus leading to deterioration in clinical examination and
worsened outcome. Both of our patients with isolated BA
occlusions did well following embolectomy, even with
a prolonged ischemic interval between time of symptom onset
and therapy. This may be related to acute establishment of
robust collateral ﬂow.
Our data suggest a beneﬁt to timely revascularization in
LVPAIS, demonstrating an improvement in standard stroke
outcomes. However, this conclusion must be interpreted with
caution in the absence of a control cohort. The two patients
presenting with a low NIHSS score in our series returned to
baseline by the time of discharge with a mean improvement in
their NIHSS score of 2. Both were independent with mRS scores
of 0 at 90 days. The other two patients with more severe
neurologic deﬁcits also improved but differed in their degree of
improvement and stroke burden documented by MRI. Patient 2
presented with an NIHSS score of 12, which improved to 3 at
discharge, and a mRS score of 1 at 90 days. Patient 1 presented
with an NIHSS score of 17 which only minimally improved to
16 at discharge. Her score reﬂected an improvement in mental
status but regression in motor function. Her mRS score of 3
remained unchanged at 30 and 90 days. She was younger and
had a more extensive area of ischemia including involvement of
both anterior and posterior circulation and the cortical and deep
gray structures. Both younger age and simultaneous involve-
ment of cortical and deep gray structures have been shown to
predict a worse outcome in children.7
Others have echoed our ﬁndings. Grunwald et al12 also
described signiﬁcant improvement in one of their patients who
presented with an NIHSS score of 26 which improved to 0 at
discharge and a modest improvement in their other patient from
an NIHSS score of 36 to 23 at discharge. They did not report
post-treatment imaging ﬁndings, mRS scores or functional
outcome. Tsivgoulis et al13 reported improvement in their
patient from an NIHSS score of 15 to 9 at 24 h and further
improvement in the NIHSS score to 2 and an mRS score of 1 at
3 months.
This study has several limitations. First, it is based on a small
sample size, reﬂecting the incidence of large vessel ischemic
stroke in the pediatric population. Second, it was retrospective
without a control group, representing a bias towards endovas-
cular therapy. Finally, availability and past experience inﬂuenced
the operator ’s choice of device and there were no guidelines
regarding the number of attempts that could be made with
a particular embolectomy device before considering it a failed
attempt at recanalization. The variability in the operator ’s
choice of device, lack of a control group and small sample size
limits the strength of any conclusion that can be drawn from
these data. However, the objective of this study was not to
prove safety or superiority but to introduce a concept that may
be further evaluated with future collaborative efforts.
In conclusion, mechanical embolectomy using the Merci or
Penumbra systems for the treatment of LVPAIS may be a safe
and potentially effective therapeutic option. It has the advan-
tage of avoiding uncertain dosing regimens of thrombolytic
agents in children. It may also be used beyond the typical
therapeutic window of thrombolytics, as is often the case in the
pediatric age group. These results should be viewed with caution
given the context of the study. Future work should focus on the
limitations of mechanical embolectomy in children and deﬁning
treatment windows using a cooperative effort in view of the low
incidence of the disease.
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